VBVeronica Bisagno

Veronica Bisagno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veronica Bisagno has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Francisco José Urbano

    IFIByNE, Universidad de Buenos Aires, Buenos Aires, Argentina, Argentina

    4 shared publications
  • Ignacio Carrera

    Departamento de Química Orgánica, Facultad de Química, Universidad de la República, 11800, Montevideo, Uruguay

    2 shared publications
  • Maria Sofia Villalba

    IIMT, Austral University, Buenos Aires, Argentina, Argentina

    2 shared publications
  • Pablo Torterolo

    Departamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay

    2 shared publications
  • Sofía Villalba

    Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, CONICET-Universidad Austral, Buenos Aires, Argentina

    2 shared publications
  • Agustín Martínez Christensen

    Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, CONICET-Universidad Austral, Buenos Aires, Argentina

    1 shared publication

Latest Publications

  • Open Access

    Systemic HDAC Inhibition Changes Glutamatergic Neuronal Properties in Prefrontal Cortex and Ventrobasal Thalamus

    by Veronica Bisagno, Maria Sofia Villalba, Francisco J. Suarez

    Reversible protein acetylation controlled by histone deacetylases (HDACs) regulates neuronal gene expression and, increasingly, membrane physiology. We previously showed that pedunculopontine nucleus (PPN) gamma-band oscillations require class IIa HDAC activity, whereas class I inhibition was comparatively benign for that readout. Whether systemic HDAC inhibition acts uniformly across the forebrain, and across different neuronal nuclei, is unknown. Here we administered acute single systemic doses of the class I inhibitor MS275 (entinostat) and the class IIa inhibitor MC1568 to mice and performed whole-cell recordings in two functionally distinct, anatomically unconnected structures: medial prefrontal cortex (mPFC) and the ventrobasal complex (VB) of the thalamus. In mPFC pyramidal neurons we assessed short-term plasticity using paired-pulse stimulation and quantifying paired-pulse ratio (PPR); in VB neurons we quantified action-potential amplitude and the maximal rate of rise of the spike from phase-plot analysis. MS275 shifted PPR from facilitation toward depression on both mPFC and VB glutamatergic transmission, a significant change relative to vehicle, while MC1568 produced an intermediate, non-significant effect. In addition, MS275 reduced action-potential amplitude and markedly decreased the maximal rate of rise (dV/dt) of the spike in VB neurons. Thus, class I HDAC inhibition predominantly affected presynaptic glutamate release whilst affecting intrinsic properties of thalamocortical neurons. These results suggest that the consequences of systemic HDAC inhibition are class- and region-specific.

  • Psychedelics and the thalamocortical system: A scoping review

    by Sofía Villalba, Agustín Martínez Christensen, Lucia Di Costanzo, Pablo Torterolo, Ignacio Carrera, Francisco J. Urbano, Verónica Bisagno

  • Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner

    by Sofía Villalba, Sofia Bosch, Lucia Di Constanzo, Bruno González, Pablo Torterolo, Ignacio Carrera, Francisco J. Urbano, Veronica Bisagno


  • Open Access

    5-HT2A Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration

    by Sofía Villalba, Bruno González, Stephanie Junge, Alejandra Bernardi, Joaquín González, Catherine Fagúndez, Pablo Torterolo, Ignacio Carrera, Francisco J. Urbano, Verónica Bisagno

    Noribogaine (noribo) is the primary metabolite from ibogaine, an atypical psychedelic alkaloid isolated from the root bark of the African shrub Tabernanthe iboga. The main objective of this study was to test the hypothesis that molecular, electrophysiological, and behavioral responses of noribo are mediated by the 5-HT2A receptor (5-HT2AR) in mice. In that regard, we used male and female, 5-HT2AR knockout (KO) and wild type (WT) mice injected with a single noribo dose (10 or 40 mg/kg; i.p.). After 30 min., locomotor activity was recorded followed by mRNA measurements by qPCR (immediate early genes; IEG, glutamate receptors, and 5-HT2AR levels) and electrophysiology recordings of layer V pyramidal neurons from the medial prefrontal cortex. Noribo 40 decreased locomotion in male, but not female WT. Sex and genotype differences were observed for IEG and glutamate receptor expression. Expression of 5-HT2AR mRNA increased in the mPFC of WT mice following Noribo 10 (males) or Noribo 40 (females). Patch-clamp recordings showed that Noribo 40 reduced the NMDA-mediated postsynaptic current density in mPFC pyramidal neurons only in male WT mice, but no effects were found for either KO males or females. Our results highlight that noribo produces sexually dimorphic effects while the genetic removal of 5HT2AR blunted noribo-mediated responses to NMDA synaptic transmission.